Journal of Clinical Medicine · 2022 · 10 citations · 38 references
Life SciencesImmunologyPharmacologyCell SignalingImmunopathologyInflammationAnti-inflammatory PharmacologyGastrointestinal ImmunologyGastrointestinal InflammationGut-associated Lymphoid TissueInflammatory Bowel DiseaseInflammatory SignalingBleedingColonic BleedingColonic PathologyInflammatory Bowel Disease ModelsInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathophysiologyStat3 SignalingTransgenic Mice
Crohn’s disease (CD), is an inflammatory bowel disease that can affect any part of the gastro-intestinal tract (GI) and is associated with an increased risk of gastro-intestinal cancer. In the current study, we determined the role of genetic and small-molecule modulation of STAT3 in a mouse model of CD. STAT3 has 2 isoforms (α, β) which are expressed in most cells in a 4:1 ratio (α: β). STAT3α has pro-inflammatory and anti-apoptotic functions, while STAT3β has contrasting roles. We used an animal model of CD consisting of intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid and examined the severity of CD in transgenic-mice that express only STAT3α (∆β/∆β), as well as in wild-type (WT) mice administered TTI-101 (formerly C188-9), a small molecule STAT3 inhibitor. We determined that clinical manifestations of CD, such as mortality, rectal-bleeding, colonic bleeding, diarrhea, and colon shortening, were exacerbated in ∆β/∆β transgenic versus cage-control WT mice, while they were markedly decreased by TTI-101 treatment of WT mice. TTI-101 treatment also increased apoptosis of pathogenic CD4+ T cells and reduced colon levels of IL-17-positive cells. Our results indicate that STAT3 contributes to CD and that targeting of STAT3 with TTI-101 may be a useful approach to treating CD.
38
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Jean‐Pierre Hugot, Mathias Chamaillard, Habib Zouali et al. · Nature · 2001 · 5.6K citations
Raja Atreya, Jonas Mudter, Susetta Finotto et al. · Nature Medicine · 2000 · 1.3K citations
Life Sciences, Immunology, Pathology +17